Pfizer Inks Marketing Pact With Claris

Anonymous User | Login

Published: 20-May-2009

Pfizer has entered into a marketing agreement with Claris Lifesciences, an Indian firm specialising in injectables. As per the agreement, Pfizer gains marketing rights for Claris’s 15 injectable products spread across various therapeutic areas such as pain and anti-infectives. Pfizer will market these products under its brand name.

The deal extends reach of Claris’s products in Europe, North America and Australia.

Pfizer will undertake the commercialisation of the products that have gone off-patent in the western markets. The move will expand Pfizer’s generic drugs portfolio.

Claris manufactures and markets injectables with emphasis on New Drug Delivery Systems for treatment of critical illnesses and diseases.

Merck To Release Tredaptive In Mexico, Germany, UK

Merck & Co., has revealed its plans to roll out Tredaptive (ER niacin/laropiprant) in Mexico, Germany and the UK, by the third quarter of the year. Tredaptive, also calle ...

Glaxo to make Swine-Flu Vaccine

GlaxoSmithKline (Glaxo) is planning to produce a vaccine against the current strain of the A/H1N1 virus, responsible for the outbreak of swine-flu worldwide. Glaxo is try ...

Glaxo Provides 50m Pandemic Vaccines

In order to support governments and health authorities around the world to respond to the outbreak of global flu, British pharmaceutical giant GlaxoSmithKline has offered ...

Cancer Research UK, GSK To Jointly Develop Anti-cancer Drug

Cancer Research UK and Cancer Research Technology (CRT) will commence the phase I clinical trial of GlaxoSmithKline's (GSK) anti-cancer drug 1070916A, an aurora kinase in ...

US States Join Medicaid’s Lawsuits Against Wyeth

The US Justice Department has joined forces with 16 states in a legal fight against Wyeth, alleging that the drug maker has failed to reimburse hundreds of millions of do ...

PTC Enters Into Research, Licensing Agreement With Roche

For the development of orally bioavailable small molecules utilizing PTC's technology GEMS ...

Cancer Research UK, GSK To Jointly Develop Anti-cancer Drug

Cancer Research UK and Cancer Research Technology (CRT) will commence the phase I clinical trial of GlaxoSmithKline's (GSK) anti-cancer drug 1070916A, an aurora kinase in ...

Glaxo Provides 50m Pandemic Vaccines

In order to support governments and health authorities around the world to respond to the outbreak of global flu, British pharmaceutical giant GlaxoSmithKline has offered ...

Merck To Release Tredaptive In Mexico, Germany, UK

Merck & Co., has revealed its plans to roll out Tredaptive (ER niacin/laropiprant) in Mexico, Germany and the UK, by the third quarter of the year. Tredaptive, also calle ...

Glaxo to make Swine-Flu Vaccine

GlaxoSmithKline (Glaxo) is planning to produce a vaccine against the current strain of the A/H1N1 virus, responsible for the outbreak of swine-flu worldwide. Glaxo is try ...

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://drugdiscovery.pharmaceutical-business-review.com/news/pfizer_inks_marketing_pact_with_claris_090520/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BaseCon

IT Pharma Solutions ...

ETS Nederland BV

(Experimental Toxicology Services) ...

TNO

Pharma Services: From Discovery to the Clinic ...

Fraunhofer ITEM

Human Health Research ...

Anoto

Providing Unique Technology for Digital Pen and Paper ...

ProtNeteomix

Developing Applications for Drug Discovery & Development and Diagnostics ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Related Companies

Pfizer Inc.

Pfizer Inc. (Pfizer) is a global research based pharmaceutical company principally focu ...

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH (Boehringer) is a group of companies engaged in the research, ...

Merck & Co., Inc.

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company engaged in ...

Amgen Inc.

Amgen Inc. (Amgen) is a biotechnology company that is focused on the discovery, develo ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

Suppliers Product News

Amarna Therapeutics B.V. and TNO Announce SVac Research and Development Partnership

Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.

Organisations Throwing Mobile Technology at Problems With Little Consideration of Actual User and Business Needs, Quocirca

Survey reveals detrimental impact on organisational effectiveness and IT expenditure in healthcare and finance across the UK, France, Germany and the US.

Digital Pen and Paper Technology Helps Accelerate Clinical Trials

Digital pen and paper technology captures handwritten clinical data electronically, quickly and securely to save time and cost in drug discovery process.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750